- Home
- AUTL vs QSI Comparison
AUTL vs QSI Comparison
Compare AUTL & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- QSI
- Stock Information
- Founded
- AUTL 2014
- QSI 2013
- Country
- AUTL United Kingdom
- QSI United States
- Employees
- AUTL N/A
- QSI N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- AUTL Health Care
- QSI Health Care
- Exchange
- AUTL Nasdaq
- QSI Nasdaq
- Market Cap
- AUTL 625.4M
- QSI 219.8M
- IPO Year
- AUTL 2018
- QSI N/A
- Fundamental
- Price
- AUTL $2.31
- QSI $1.90
- Analyst Decision
- AUTL Strong Buy
- QSI Strong Buy
- Analyst Count
- AUTL 5
- QSI 3
- Target Price
- AUTL $9.32
- QSI $2.38
- AVG Volume (30 Days)
- AUTL 2.5M
- QSI 7.9M
- Earning Date
- AUTL 08-07-2025
- QSI 08-06-2025
- Dividend Yield
- AUTL N/A
- QSI N/A
- EPS Growth
- AUTL N/A
- QSI N/A
- EPS
- AUTL N/A
- QSI N/A
- Revenue
- AUTL $9,011,000.00
- QSI $3,443,000.00
- Revenue This Year
- AUTL $461.76
- QSI $77.57
- Revenue Next Year
- AUTL $112.66
- QSI $251.34
- P/E Ratio
- AUTL N/A
- QSI N/A
- Revenue Growth
- AUTL N/A
- QSI 167.94
- 52 Week Low
- AUTL $1.11
- QSI $0.61
- 52 Week High
- AUTL $5.00
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- AUTL 64.81
- QSI 56.65
- Support Level
- AUTL $1.98
- QSI $1.87
- Resistance Level
- AUTL $2.35
- QSI $2.14
- Average True Range (ATR)
- AUTL 0.12
- QSI 0.14
- MACD
- AUTL -0.01
- QSI 0.01
- Stochastic Oscillator
- AUTL 72.15
- QSI 59.32
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.